Drug intelligence / Profile preview

Fluviral

Development stage
Unknown
Lead developer
GSK
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

GSK1557482A is a thimerosal-free formulation of Fluviral, a trivalent inactivated influenza vaccine (TIV) developed by GSK. It is an egg-derived, split-virion vaccine designed to provide active immunization against influenza virus subtypes A and B. This specific formulation was evaluated in pediatric populations (6 months to 3 years of age) to assess safety and immunogenicity at different dose levels (0.25 mL and 0.5 mL) compared to licensed vaccines like Vaxigrip or Fluzone. As a trivalent vaccine, it typically contains antigens from two influenza A strains (H1N1 and H3N2) and one influenza B strain, following WHO recommendations for the relevant season.

Brand names
Fluviral
Other names
thimerosal-free FluviralGSK Biologicals' influenza vaccine GSK1557482ATrivalent Influenza Vaccine
02

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on Fluviral.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fluviral.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call